The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy

Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS_2 Score: A Subgroup Analysis of the RE-LY Trial

(2013) Jonas Oldgren   ANNALS OF INTERNAL MEDICINE

Antithrombotic Therapy for Atrial Fibrillation

(2012) John J. You et al.   CHEST

Risk Factors for Stroke and Thromboembolism in Relation to Age Among Patients With Atrial Fibrillation

(2011) Jonas Bjerring Olesen et al.   CHEST

Apixaban in Patients with Atrial Fibrillation

(2011) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Moving the Tipping Point

(2010) Mark H. Eckman et al.  

Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

(2010) et al.   EUROPEAN HEART JOURNAL

A comparison of risk stratification schemes for stroke in 79 884 atrial fibrillation patients in general practice

(2010) T. P. VAN STAA et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers

(2010) Michael J. Pencina et al.   STATISTICS IN MEDICINE

Identifying Patients at High Risk for Stroke Despite Anticoagulation

(2010) Gregory Y.H. Lip et al.   STROKE

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

(2009) Gregory Y.H. Lip et al.   CHEST

Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation

(2009)   NEW ENGLAND JOURNAL OF MEDICINE